Tvardi Therapeutics (TVRD) Net Margin (QoQ) (2013 - 2025)
Tvardi Therapeutics (TVRD) Net Margin (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - |
| 10 | Tvardi Therapeutics | 17.59 Mn | 17.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 36,383.00 |
| Dec 31, 2024 | -35,032.00 |
| Sep 30, 2024 | 32,966.00 |
| Jun 30, 2024 | 73,730.00 |
| Mar 31, 2024 | -35,115.00 |
| Dec 31, 2023 | -47,959.00 |
| Sep 30, 2023 | -14,899.00 |
| Jun 30, 2023 | -82.00 |
| Mar 31, 2023 | 50,239.00 |
| Dec 31, 2022 | -73,168.00 |
| Sep 30, 2022 | -21,113.00 |
| Jun 30, 2022 | 62,263.00 |
| Mar 31, 2022 | 341,101.00 |
| Dec 31, 2021 | -406,102.00 |
| Mar 31, 2021 | -127,492.00 |
| Dec 31, 2020 | 24,891.00 |
| Sep 30, 2020 | 26,677.00 |
| Jun 30, 2020 | -8,757.00 |
| Sep 30, 2019 | -30,949.00 |
| Jun 30, 2019 | 30,486.00 |